Technical Analysis for CNSP - CNS Pharmaceuticals, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Pocket Pivot | Bullish Swing Setup | -11.25% | |
Volume Surge | Other | -11.25% | |
Bollinger Band Squeeze | Range Contraction | -11.25% | |
BB Squeeze + Upper Band Touch | Range Contraction | -11.25% | |
Upper Bollinger Band Touch | Strength | -11.25% | |
Crossed Above 20 DMA | Bullish | -1.84% | |
Pocket Pivot | Bullish Swing Setup | -1.84% | |
Bollinger Band Squeeze | Range Contraction | -1.84% | |
Gapped Up | Strength | -1.84% | |
Fell Below 20 DMA | Bearish | 5.45% |
Alert | Time |
---|---|
Gap Down Partially Closed | about 6 hours ago |
20 DMA Support | about 6 hours ago |
10 DMA Support | about 6 hours ago |
2x Volume Pace | about 6 hours ago |
1.5x Volume Pace | about 6 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
CNS Pharmaceuticals, Inc., a preclinical stage pharmaceutical company, focuses on the development of anti-cancer drug candidates for the treatment of primary and metastatic brain, and central nervous system tumors. Its lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma. The company was founded in 2017 and is based in Houston, Texas.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Oncology Blastoma Glioblastoma Stage Pharmaceutical Brain Tumor Evofosfamide Central Nervous System Tumors
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Cancer Oncology Blastoma Glioblastoma Stage Pharmaceutical Brain Tumor Evofosfamide Central Nervous System Tumors
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.98 |
52 Week Low | 0.19 |
Average Volume | 293,542 |
200-Day Moving Average | 1.14 |
50-Day Moving Average | 0.29 |
20-Day Moving Average | 0.22 |
10-Day Moving Average | 0.22 |
Average True Range | 0.03 |
RSI (14) | 48.72 |
ADX | 21.36 |
+DI | 23.28 |
-DI | 15.70 |
Chandelier Exit (Long, 3 ATRs) | 0.18 |
Chandelier Exit (Short, 3 ATRs) | 0.28 |
Upper Bollinger Bands | 0.24 |
Lower Bollinger Band | 0.19 |
Percent B (%b) | 0.92 |
BandWidth | 25.97 |
MACD Line | -0.02 |
MACD Signal Line | -0.03 |
MACD Histogram | 0.0079 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.32 | ||||
Resistance 3 (R3) | 0.32 | 0.29 | 0.31 | ||
Resistance 2 (R2) | 0.29 | 0.27 | 0.29 | 0.30 | |
Resistance 1 (R1) | 0.27 | 0.26 | 0.28 | 0.27 | 0.30 |
Pivot Point | 0.24 | 0.24 | 0.25 | 0.24 | 0.24 |
Support 1 (S1) | 0.22 | 0.22 | 0.23 | 0.21 | 0.18 |
Support 2 (S2) | 0.19 | 0.21 | 0.19 | 0.18 | |
Support 3 (S3) | 0.16 | 0.19 | 0.18 | ||
Support 4 (S4) | 0.16 |